Anagram Therapeutics's $250M: A Big Biotech Bet Amid AI's Spotlight
Anagram Therapeutics raised $250M in May 2026, one of the largest biotech rounds of the period, proving life-sciences capital is alive alongside AI.
Healthtech Venture Capital & Digital Health Funding
Healthtech venture capital spans digital health platforms, care delivery innovation, diagnostics, and AI-enabled clinical workflows. Our healthtech coverage tracks the funding rounds and fund strategies defining the next generation of healthcare technology.
Healthtech VC Themes
- Digital health: Telehealth, care navigation, and patient engagement
- AI in healthcare: Clinical decision support, documentation, and operations
- Biopharma adjacencies: Drug discovery tools and life-sciences infrastructure
- Payer & provider tech: Revenue cycle, benefits, and workforce solutions
Browse healthtech venture capital articles below.
Related Articles (62 articles)
-
-
How Much Did Adaptyv Raise? $40M Series A, No Valuation
Adaptyv closed a $40 million Series A led by Highland Europe. Y Combinator, ACE Ventures, and byFounders returned. Valuation was not disclosed. The company says throughput grew more than 5x and names Chai Discovery, Boltz, Roche, and Novo Nordisk as customers.